An unusual presentation of T-lymphoma in a Crohn's disease patient treated with combo therapy: we are willing to take a risk of serious adverse events for a doubtful benefit?

J Crohns Colitis. 2012 Oct;6(9):954-5. doi: 10.1016/j.crohns.2012.04.017. Epub 2012 Jul 7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Antibodies, Monoclonal / adverse effects*
  • Crohn Disease / drug therapy*
  • Drug Therapy, Combination / adverse effects
  • Fatal Outcome
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Infliximab
  • Lymphoma, T-Cell / chemically induced*
  • Lymphoma, T-Cell / drug therapy
  • Male
  • Mercaptopurine / adverse effects*
  • Middle Aged

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Infliximab
  • Mercaptopurine